Omkipo (Timolol Maleate)

Timolol Maleate, the active ingredient in Omkipo, is a non-selective beta‑adrenergic blocker presented as a ophthalmic solution for topical eye use. It lowers intra‑ocular pressure in patients with ocular hypertension and helps manage open‑angle glaucoma. GNH USA supplies Omkipo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omkipo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Timolol Maleate is a beta‑blocker that reduces intra‑ocular pressure by acting on the eye’s aqueous humor dynamics.

- Open‑angle glaucoma: helps lower intra‑ocular pressure to slow disease progression. - Ocular hypertension: reduces pressure to prevent conversion to glaucoma. - Secondary glaucoma: assists in pressure control when other causes are present.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Burning or stinging sensation in the eye. - Temporary blurred vision. - Dry eye or foreign‑body sensation. - Conjunctival hyperemia (redness). - Mild headache.

Serious or Rare Side Effects: - Bradycardia or marked slowing of heart rate. - Significant hypotension. - Bronchospasm in patients with reactive airway disease. - Severe allergic reaction (anaphylaxis). - Vision loss related to ocular irritation. - Persistent corneal edema.

When ​  ​        ​           ...  …  ... ...  …  … … … … … … … … … … …

-  ");